Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

UK trial aims to find treatments that can slow or reverse motor neurone disease

January 17, 2020 Medical Communications MND, Motor Neurone, clinical trial, motor neurone disease, trial

A UK wide trial called MND-SMART has invited hundreds of people with motor neurone disease (MND) to participate. It will …
News
mask-1954673_1280

China’s viral pneumonia spreads to Japan

January 17, 2020 Medical Communications China, Japan, Sars, Viral pneumonia, Wuhan, epidemic, pandemic, pneumonia

A recent strain of viral pneumonia has spread from China to Japan, prompting fears of a global pandemic. A man …
News
novo_nordisk_flag

Novo’s semaglutide injection and tablets get expanded FDA approval for type 2 diabetes with established CVD

January 17, 2020 Medical Communications, Sales and Marketing FDA, Novo Nordisk, Ozempic, cardiovascular disease, diabetes, pharma

Novo Nordisk has seen label expansions approved from the FDA for both its glucagon-like peptide-1 (GLP-1) analogue injection Ozempic (once-weekly …
News
jp-kress_mor

Working Life Interview: Jean-Paul Kress, CEO of MorphoSys

January 13, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Working Life, feature, morphosys, pharma

With a medical doctorate as well as degrees in pharmacology and immunology under your belt, was your path always to …
Feature
1201709115_133b3927a3_b

Bayer and Exscientia to work together on AI in cardiovascular and oncology drug discovery

January 10, 2020 Medical Communications Bayer, Exscientia, oncology

Bayer AG has partnered with Exscientia to accelerate the discovery of small molecule drugs focused on cardiovascular disease and oncology. …
News

Sanofi secures expanded European approval for Toujeo in type 1 diabetes

January 10, 2020 Medical Communications, Sales and Marketing EU, Sanofi, pharma, toujeo

Sanofi has revealed that the European Commission has expanded the existing label for Toujeo (insulin glargine 300 units/mL) to include …
News
48612088061_36c0f87278_b

Idorsia reveals it is working with Neurocrine on new epilepsy drug deal

January 10, 2020 Medical Communications FDA, Idorsia, Neurocrine, drugs, epilepsy, pharma

Idorsia revealed its 2019 deal for its investigational epilepsy medicine was with Neurocrine Biosciences, and it is potentially worth more …
News

US approval for Blueprint Medicines’ gastrointestinal stromal tumour therapy

January 10, 2020 Medical Communications, Sales and Marketing Ayvakit, Blueprint Medicines, Cancer, pharma

The FDA has moved to authorise Blueprint Medicines’ kinase inhibitor Ayvakit (avapritinib) for the treatment of unresectable or metastatic gastrointestinal …
News
4420456374_64a3d7e6aa_88

Top Ten most popular articles on Pharmafile.com this week

January 10, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The US pharamaceutical industry dominates the news this week, with Pfizer, Sanofi and GlaxoSmithKline all increasing their drug prices while …
News
rami-levin-picture-3-002

Saniona appoints Rami Levin as President and Chief Executive Officer

January 8, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointments, rare diseases

Saniona has announced that Rami Levin will take over as the Chief Executive Officer of the company as it seeks …
Appointment
enrique_conterno

FibroGen names Lilly veteran as new CEO

January 7, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, fibrogen, pharma

Eli Lilly veteran Enrique Conterno has been revealed as the new Chief Executive Officer of FibroGen following the unexpected death …
Appointment

Novo Nordisk to offer US patient’s in immediate need free insulin

January 3, 2020 Medical Communications Novo, Novo Nordisk, Type 1 diabetes, diabetes, insulin, type 2 diabetes

Novo Nordisk said it would offer free, one-time supply of insulin to those in need, amidst rising insulin prices. Novo …
News

Single cycle of chemo is just as effective as two in treating testicular cancer, study finds

January 3, 2020 Medical Communications Cancer, Men's Cancer, chemo, chemotherapy, testicular cancer

A new study shows that testicular cancer can be successfully treated with less rounds of chemotherapy. The recent study, published …
News
47028496254_21a33b62df_b

NICE rules against the use of Akcea’s Waylivra in the NHS

January 3, 2020 Medical Communications Akcea, European Commission, FCS, NHS, NICE

NICE has not recommended Akcea’s drug Waylivra (volanesorsen) to be used for the treatment of Familial Chylomicronaemia Syndrome (FCS) in …
News
19916066779_1a281ebca0_b

Johnson & Johnson sued by Washington State for role in the opioid crisis

January 3, 2020 Medical Communications Bernie Sanders, Johnson & Johnson, OxyContin, fentanyl, opioid crisis, opioids

The state of Washington sued pharmaceutical company Johnson & Johnson for deceptive marketing that said their opioids were effective for …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025